TLDR
- M&A execution window opens: Valuation gaps narrow, dry powder deploys, regulatory clarity improves—corporates and sponsors shift from defence to deliberate portfolio reshaping
- Venezuelan crude reverses supply shock logic: Oil oversupply drives disinflation, reshaping energy M&A toward infrastructure and transition assets rather than upstream expansion
- Currency arbitrage favours transatlantic deals: USD depreciation makes U.S. targets attractively priced for European and Swiss acquirers on a currency-adjusted basis
- Regulated industries consolidate aggressively: Healthcare (biopharma patents), financial services (compliance costs), and utilities (grid modernisation) drive sectoral deal flow
As 2026 opens, global markets enter a phase defined by strategic reallocation rather than crisis response. After two years dominated by inflation containment, geopolitical shocks, and aggressive monetary tightening, the macroeconomic environment has shifted toward selective growth re-acceleration, particularly in the United States¹,². Fiscal stimulus enacted in late 2025, combined with moderating inflation and a pause in monetary tightening, has improved forward-looking confidence among corporate decision-makers³,⁴.
Western Europe and Switzerland present a more moderate growth profile, constrained by structural demographics and fiscal discipline, yet supported by easing inflation and improved policy visibility⁴. Across regions, dispersion in growth, capital costs, and currency dynamics has become a defining feature of the 2026 environment, elevating the importance of active capital allocation and cross-border strategy.
For M&A and private capital markets, this marks a transition from defensive positioning toward deliberate portfolio reshaping, particularly in regulated industries where scale, compliance efficiency, and technological capability increasingly determine competitive advantage⁵,⁶.
Geopolitics and Energy: A Reversal of the Supply Shock Narrative
Geopolitical risk has re-entered market pricing, most visibly through the U.S.-brokered political transition in Venezuela and the subsequent reintroduction of Venezuelan crude into global oil supply chains⁷,⁸. Contrary to traditional supply-shock scenarios, markets interpreted this development as disinflationary, with oil prices declining amid expectations of structural oversupply⁹,¹⁰.
OPEC+ production normalisation and continued output growth from the United States, Brazil, and Guyana reinforce projections of excess supply through 2026⁹,¹¹. Neumarz recently advised a Geneva-based wine distribution group on a cross-border acquisition structured to benefit from stable commodity input costs and favourable CHF-EUR exchange dynamics. The transaction consolidated supply chains across Switzerland and France while securing long-term procurement agreements with European vineyards, demonstrating how energy price stability enables strategic positioning in regulated food and beverage sectors. Yet geopolitical intervention risk persists where natural resources intersect with strategic interests.
Energy M&A now concentrates on infrastructure, transition assets, and regulated utilities rather than upstream expansion, where long-dated cash flows and policy alignment support valuation resilience¹²,¹³.
Rates, FX, and Cross-Border Capital Allocation
Interest rates across developed markets have reached an inflexion point. The U.S. Federal Reserve has signalled a transition from restrictive policy toward optional easing, contingent on inflation persistence³. The European Central Bank and Swiss National Bank have similarly adopted holding stances as price stability improves⁴.
Foreign-exchange dynamics regain strategic relevance as the U.S. dollar depreciated against the euro and Swiss franc through 2025, materially altering cross-border acquisition economics¹⁴,¹⁵. Neumarz advised on relocating an Asian technology firm’s European headquarters from the UK to Switzerland, where currency stability, talent access, and regulatory predictability delivered a projected 18% reduction in three-year operational costs despite higher nominal wage rates. The analysis demonstrated that CHF appreciation against Asian currencies offset establishment costs within 24 months. USD-denominated credit instruments offer yield premia even after hedging costs, supporting leveraged acquisition structures¹⁴,¹⁶.
FX volatility persists despite range-bound expectations, driven by fiscal divergence and geopolitical shifts². Transaction structuring, financing decisions, and portfolio construction require active currency risk management rather than passive acceptance of spot rates.
M&A Outlook: From Hesitation to Execution
Global M&A recovers in 2026 as valuation gaps narrow, private-capital dry powder deploys, and corporate boards gain strategic clarity⁵,⁶. Dealmaking now prioritises strategic fit, regulatory durability, and long-term value creation over multiple expansion—a pharmaceutical client recently walked from an auction due to regulatory uncertainty, redirecting capital toward a negotiated carve-out with pre-cleared antitrust pathways.
Carve-outs and portfolio rationalisation are expected to represent a growing share of deal flow as corporates and financial institutions streamline operations and redeploy capital¹⁷. Deal structures increasingly incorporate earn-outs, minority rollovers, and seller financing to manage valuation uncertainty and financing costs⁵.
Regulatory scrutiny remains a defining constraint, particularly in cross-border transactions involving critical infrastructure, healthcare, financial services, and advanced technology¹³,¹⁸. Successful execution in 2026 will depend on early regulatory engagement and robust risk-allocation mechanisms embedded in transaction documentation.
Regulated Industries: Sectoral Implications
Healthcare and life sciences remain central to the 2026 M&A thesis. Patent expirations, R&D productivity pressures, and capital discipline continue to drive consolidation, with biopharma deal values rebounding strongly in 2025 and momentum extending into 2026¹⁹,²⁰. Transactions increasingly combine traditional assets with digital health, data, and AI-driven capabilities, increasing both strategic value and regulatory complexity²⁰.
Financial services enter 2026 with renewed consolidation pressure. Rising compliance costs, technology investment requirements, and capital-efficiency considerations favour scale, particularly among mid-sized banks and asset managers¹³,¹⁸. Private credit and alternative-asset platforms continue to attract capital as banks retrench from balance-sheet-intensive activities¹⁶.
Energy, utilities, and infrastructure transactions are expected to focus on grid modernisation, renewable integration, and regulated network assets, benefiting from policy alignment and predictable cash flows¹¹,²¹.
Technology increasingly functions as an embedded capability rather than a standalone sector. Acquisitions of AI, cybersecurity, and data-infrastructure firms by regulated incumbents are expected to accelerate, driven by operational necessity rather than speculative growth¹⁸,²⁰.
Strategic Implications for Neumarz Clients
For corporates, 2026 represents an execution window. Balance sheets remain strong, financing conditions are stabilising, and strategic urgency has returned. Successful acquirers will focus on capability-driven transactions, disciplined valuation, and regulatory foresight.
For family offices, the environment supports diversification into private credit, infrastructure, and co-investments alongside experienced sponsors. Currency-aware allocation and selective exposure to regulated assets can enhance resilience while preserving optionality in an uncertain geopolitical landscape¹⁴,¹⁶.
Preparation Over Reaction: Neumarz’s Transatlantic Advantage
The 2026 market environment rewards preparation over reaction. Macroeconomic stabilisation, shifting geopolitics, and regulatory complexity combine to create a landscape where informed, cross-border advisory is critical. Neumarz enters the year positioned to support clients navigating this transition, leveraging its transatlantic perspective and sector expertise to convert uncertainty into opportunity.
This analysis uses AI-assisted research and sourcing. All content has been reviewed and verified by Haider Alleg, Managing Partner Europe, and Sam Bidwell, Partner US Operations, at Neumarz.
References
- PwC. Global Economy Watch: Growth and Inflation Outlook. PwC Research, Q4 2025.
- IMF. World Economic Outlook: Navigating Policy Normalisation. International Monetary Fund, October 2025.
- Federal Reserve. Summary of Economic Projections. Federal Open Market Committee, December 2025.
- European Central Bank. Economic Bulletin and Monetary Policy Decisions. ECB, Q4 2025.
- PwC. Global M&A Industry Trends: 2026 Outlook. PwC Deals, 2025.
- McKinsey & Company. The Future of M&A in a Higher-for-Longer Rate Environment. 2025.
- Reuters. US Brokers Venezuelan Oil Deal Following Political Transition. January 2026.
- Al Jazeera. Venezuela’s Oil Industry After Regime Change. January 2026.
- International Energy Agency. Oil Market Report: Medium-Term Outlook 2026. IEA, December 2025.
- World Bank. Commodity Markets Outlook: Energy. World Bank Group, October 2025.
- OECD. Infrastructure and Energy Investment Outlook. OECD, 2025.
- World Bank. Infrastructure and Energy Transition Investment Outlook. 2025.
- OECD. FDI Regulatory Developments in Advanced Economies. OECD Investment Policy Monitor, 2025.
- Bank for International Settlements. Global Liquidity and Cross-Border Capital Flows. BIS Quarterly Review, December 2025.
- Bloomberg. EUR/USD and CHF Exchange Rate Data. Bloomberg Terminal, January 2026.
- Refinitiv. Global Credit Markets and Yield Differentials. January 2026.
- EY. Global Corporate Divestment and Carve-out Study. EY Parthenon, 2025.
- McDermott Will & Emery. Global M&A Trends and Regulatory Considerations. December 2025.
- Bain & Company. Life Sciences M&A Outlook. Bain Healthcare Practice, 2025.
- IQVIA Institute. Global Pharmaceutical R&D and Deal Activity Trends. 2025.
- OECD. Infrastructure Governance and Investment Frameworks. 2025.
